(Q35083647)

6 August 2017

1 reference

title

Cancer immunotherapy: the past, the present and the future (English)

1 reference

6 August 2017

1 reference

Christopher R Parish

1

1 reference

6 August 2017

1 April 2003

1 reference

Immunology & Cell Biology

6 August 2017

1 reference

6 August 2017

81

1 reference

6 August 2017

2

1 reference

6 August 2017

106-113

1 reference

Coley's toxins, tumor necrosis factor and cancer research: a historical perspective

6 August 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

BCG (Bacillus of Calmette Guerin) therapy of high-risk superficial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Actively acquired tolerance of foreign cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Immunological aspects of malignant disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Thymus and Lymphohemopoietic Cells: Their Role in T Cell Maturation in Selection of T Cells' H-2-Restriction-Specificity and in H-2 Linked Ir Gene Control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Multiple levels of peripheral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Tolerance, danger, and the extended family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

A new era for cancer immunotherapy based on the genes that encode cancer antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Strategies for immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The onset and extent of genomic instability in sporadic colorectal tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Signals arising from antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The Yin and Yang of T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Dendritic cells in cancer vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Active immunization against cancer with dendritic cells: the near future

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Dendritic cells: making progress with tumour regression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Decreased tumor surveillance in perforin-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Enhanced in vivo growth and resistance to rejection of tumor cells expressing dominant negative IFN gamma receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Differential tumor surveillance by natural killer (NK) and NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

A renaissance for the tumor immunosurveillance hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Regulation of cutaneous malignancy by gammadelta T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Dependence of the adaptive immune response on innate immunity: some questions answered but new paradoxes emerge

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Immune activation by bacterial DNA: a new genetic code

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The Toll receptor family and microbial recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Toll-like receptors: critical proteins linking innate and acquired immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Approaching the asymptote? Evolution and revolution in immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The immune system evolved to discriminate infectious nonself from noninfectious self

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Danger - pathogen on the premises! Immunological tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Is cancer dangerous to the immune system?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

What Is the Evidence That Tumors Are Angiogenesis Dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Angiogenesis and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Travellers in many guises: the origins and destinations of dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The role of dendritic cell subsets in selection between tolerance and immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Immature, but not inactive: the tolerogenic function of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

B cells inhibit induction of T cell-dependent tumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

The central role of CD4(+) T cells in the antitumor immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Distinct role of antigen-specific T helper type 1 (Th1) and Th2 cells in tumor eradication in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Murine interleukin-4 displays potent anti-tumor activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Inhibition of angiogenesis by interleukin 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Immunotherapy of cytotoxic T cell-resistant tumors by T helper 2 cells: an eotaxin and STAT6-dependent process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Eotaxin. An essential mediator of eosinophil trafficking into mucosal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

Biological implications of macrophage infiltration in human tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0818-9641.2003.01151.X

10.1046/J.0818-9641.2003.01151.X

21 January 2018

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12631233